Security key
09073Q105
- Security type / class
- Equity / ADSs
- Total 13F shares
- 221,471
- Total 13F value
- $622,000
- Share change
- -317,939
- SEC-reported price per share
- $2.81
- Number of holders
- 10
- Value change
- -$16,795,397
- Number of buys
- 6
- Number of sells
- 12
- Shares outstanding
- 592,878
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
10
Top holders
10
BVXV full security history
Ownership snapshot
Full 13F holder table
Scinai Immunotherapeutics Ltd. SEC filings
Scinai Immunotherapeutics Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of BVXV - Scinai Immunotherapeutics Ltd. - ADSs (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
IBEX INVESTORS LLC
Disclosed value leader
IBEX INVESTORS LLC
Comparable rows
0/15
Latest evidence
30 Sep 2020
13F
Highest disclosed value: $12,603,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
IBEX INVESTORS LLC has the largest disclosed position value at $12.6M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens IBEX INVESTORS LLC's linked filing trail.
Disclosed position value
Top 5
IBEX INVESTORS LLC
$12.6M
MORGAN JESS S & CO INC
$2.91M
MORGAN STANLEY
$1.9M
ARK Investment Management LLC
$776K
HighTower Advisors, LLC
$701K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| IBEX INVESTORS LLC |
13F
Company
|
—
denominator unverified
|
$12,603,000
322,413 shares
|
— | 30 Sep 2020 |
| MORGAN JESS S & CO INC |
13F
Company
|
—
denominator unverified
|
$2,911,000
74,464 shares
|
— | 30 Sep 2020 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$1,902,000
48,666 shares
|
— | 30 Sep 2020 |
| ARK Investment Management LLC |
13F
Company
|
—
denominator unverified
|
$776,000
19,856 shares
|
— | 30 Sep 2020 |
| HighTower Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$701,000
17,900 shares
|
— | 30 Sep 2020 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$645,000
16,489 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
221,471
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
18
Q4 2020 holders
10
Holder diff
-8
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 value | Q4 2020 value | Value change | Value Chg % |
|---|